[Study on effect of baoyuan qiangshen tablet no. I in prolongating interval of hemodialysis in patients of terminal-stage of renal disease].

Twenty cases of terminal stage of renal disease (TSRD) were treated with Baoyuan Qiangshen Tablet No. I(BYQS I) combined with hemodialysis once every 5 days (TCM-WM group) was observed and compared with patients treated with routine hemodialysis (once every 3 days) only (control group). Results showed that the increasing extents of serum creatinine, blood urea nitrogen of TCM-WM group at dialysis interval were all lower than that of control group (P < 0.